Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score

A soluble mesothelin-related peptide (SMRP) is the only FDA-approved biomarker for diagnosis of pleural mesothelioma (PM) and the most used for monitoring treatment. Radiological assessment of PM, based on modified RECIST (mRECIST) criteria, is challenging. This pilot study was designed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosso, Federica, Mannucci, Matilde, Ugo, Francesca, Ferro, Paola, Cassinari, Maurizio, Vigani, Antonella, De Angelis, Antonina Maria, Delfanti, Sara, Lia, Michela, Guaschino, Roberto, Barbero, Stefano, Roncella, Silvio, Giannoni, Ugo, Bertolotti, Marinella, Pistillo, Maria Pia, Fontana, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623660/
https://www.ncbi.nlm.nih.gov/pubmed/34829362
http://dx.doi.org/10.3390/diagnostics11112015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623660/
https://www.ncbi.nlm.nih.gov/pubmed/34829362
http://dx.doi.org/10.3390/diagnostics11112015

Ejemplares similares